Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ETCompany ParticipantsMichaela Pewarski - Vice President, ...

Neurocrine Biosciences, Inc. today announced the release of findings from a new survey conducted by The Harris Poll highlighting the profound negative impact of tardive dyskinesia on patients and ...

Pathos AI pulled in its biggest funding round to date. Find out how much the Chicago-born company raised, and what it means ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, iteration and aligned resources are all critical drivers of breakthroughs ...

BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Thursday reported a loss of $10.6 million in its first quarter. On a per-share basis, the Bay ...

Unity Biotechnology, a Bay Area company that once won high-profile backers and a $700 million valuation for its research into aging, is now laying off every one of its remaining employees.

Rishabh Software and S4G Consulting have teamed up to introduce SR360, a business-driven end-to-end Technology service designed to help enterprises modernize their technology without the usual ...

EAST PRINCETON, N.J. (AP) — EAST PRINCETON, N.J. (AP) — PDS Biotechnology Corporation (PDSB) on Wednesday reported a loss of $8.5 million in its first quarter. On a per-share basis ...

From left: Eric Keller of Noveome Biotherapeutics, Heidi Wagner of ElevateBio, Krish Krishnan of Krystal Biotech, and Betty Woo of Thermo Fisher Scientific, during the Life Sciences Future PA ...

April 24 (Reuters) - Shares of International Business Machines (IBM.N), opens new tab fell nearly 7% in morning trading on Thursday after the company said some of its federal contracts were ...

G enentech, one of the world’s premiere biotechnology companies and a member ... necessary infrastructure upgrades to attract future business. Even when new jobs are created in a Tier 3 county ...

UNITY Biotechnology (UBX) announced that the peer-reviewed journal NEJM Evidence published results from the Phase 2 BEHOLD study of UBX1325 in patients with diabetic macular edema. As reported in ...